Revvity, Inc. (RVTY)
101.95
-1.97
(-1.90%)
USD |
NYSE |
Dec 12, 11:12
Revvity Research and Development Expense (TTM): 206.87M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 446.00M |
| Bruker Corp. | 400.00M |
| Avantor, Inc. | -- |
| Azenta, Inc. | 28.19M |
| Harvard Bioscience, Inc. | 8.97M |